Collection of Patients' Background Information Relenza Sentinel Site Monitoring Program in Japan
Latest Information Update: 06 Sep 2023
At a glance
- Drugs Zanamivir (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Acronyms SSMP
- Sponsors GSK
Most Recent Events
- 23 Sep 2010 New trial record